PharmaJet’s Needle-free Injection System Selected to Administer DNA Immunotherapy for Advanced Melanoma in Late-stage Clinical Development following Positive Phase 2 Data
/
DateJan 09 2026
PharmaJet’s intramuscular (IM) Needle-free Injection System – Stratis® – was used to deliver Scancell’s iSCIB1+ DNA immunotherapy in combination with immune checkpoint inhibitors in the... Read More →


















